ECOG- Frequently Asked Questions about the Selenium Study (E5597)

Follow the link below to view the handout answering frequently asked questions about the ECOG Selenium Study (E5597). This is a "randomized phase III trial to determine the effectiveness of selenium in preventing the development of second primary lung tumors in patients who have undergone surgery to remove stage I non-small cell lung cancer."

Frequently Asked Questions about the Selenium Study

The document is in Adobe Acrobat format. If you do not already have Adobe Acrobat Reader running on your computer you can download this software free of charge from the Adobe web site.

Next topic